Status:
COMPLETED
Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies in Children
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Idiopathic Purpura
Eligibility:
All Genders
Up to 18 years
Brief Summary
Idiopathic purpura fulminans by anti-protein S antibody is a very rare but potentially extremely serious entity. The data in the literature are poor with only isolated report boxes and a single series...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- diagnostic of idiopathic purpura fulminans
- Acquired protein S deficiency
- Exclusion criteria:
- \- Other infecious purpura diagnosis
Exclusion
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04845113
Start Date
January 1 2021
End Date
July 31 2021
Last Update
October 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295